Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Inclusion Criteria: * Any of the following criteria: * Patients with known chronic liver diseases referred to liver-specific exams by their referring physician as part of the routine practice, including a VCTE exam, with or without a blood test, a MRI/MRE exam, a liver biopsy, * Patients screened for fibrotic NASH in the context of NASH pharmaceutical trials, for which a data sharing agreement has been signed between E-Scopics and the pharmaceutical trial promoter, * Patients who consent in written to participate in the Clinical Investigation after being orally informed on the objectives and methods of the Clinical Investigation, * European patients covered by a social security program Exclusion Criteria: * Patients under 18 years of age or over 80 years of age, * Patients with active implants such as pacemakers, defibrillators, pumps, etc. * Patients presenting wounds at the location where the ES1 probe shall be placed on patients' skin, * Adult patients under social tutorship, or unable to provide informed consent when not subject to tutorship measures, * Pregnant and breastfeeding women, * People deprived of their freedom rights * People who have been hospitalized without giving informed consent or under emergency situation, * People admitted in a social or sanitary institution for other reasons than the Clinical Investigation, * Patients included in another research study that could interfere with the present Clinical Investigation.